[go: up one dir, main page]

NL300284I2 - Kristalmodificatie van - Google Patents

Kristalmodificatie van

Info

Publication number
NL300284I2
NL300284I2 NL300284C NL300284C NL300284I2 NL 300284 I2 NL300284 I2 NL 300284I2 NL 300284 C NL300284 C NL 300284C NL 300284 C NL300284 C NL 300284C NL 300284 I2 NL300284 I2 NL 300284I2
Authority
NL
Netherlands
Prior art keywords
crystal modification
crystal
modification
Prior art date
Application number
NL300284C
Other languages
English (en)
Other versions
NL300284I1 (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300284(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL300284I1 publication Critical patent/NL300284I1/nl
Publication of NL300284I2 publication Critical patent/NL300284I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL300284C 1997-06-10 2007-07-03 Kristalmodificatie van NL300284I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003427 WO1998056772A1 (en) 1997-06-10 1998-06-08 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic

Publications (2)

Publication Number Publication Date
NL300284I1 NL300284I1 (nl) 2007-10-01
NL300284I2 true NL300284I2 (nl) 2007-11-01

Family

ID=4209650

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300284C NL300284I2 (nl) 1997-06-10 2007-07-03 Kristalmodificatie van

Country Status (37)

Country Link
US (6) US6740669B1 (nl)
EP (2) EP0994863B1 (nl)
JP (2) JP3672575B2 (nl)
KR (2) KR100409168B1 (nl)
CN (3) CN1298708C (nl)
AR (4) AR012946A1 (nl)
AT (2) ATE232852T1 (nl)
AU (2) AU725517B2 (nl)
BR (2) BR9804947A (nl)
CA (3) CA2256015C (nl)
CO (2) CO4940452A1 (nl)
CY (1) CY2007014I2 (nl)
CZ (2) CZ292481B6 (nl)
DE (3) DE69813560T2 (nl)
DK (2) DK0994864T3 (nl)
ES (2) ES2197485T3 (nl)
FR (1) FR07C0037I2 (nl)
HK (3) HK1028242A1 (nl)
HU (2) HU226107B1 (nl)
ID (2) ID27660A (nl)
IL (2) IL125733A (nl)
LU (1) LU91345I2 (nl)
MY (2) MY125854A (nl)
NL (1) NL300284I2 (nl)
NO (2) NO329314B1 (nl)
NZ (2) NZ331370A (nl)
PE (2) PE79799A1 (nl)
PL (2) PL191943B1 (nl)
PT (1) PT994864E (nl)
RU (2) RU2198167C2 (nl)
SI (2) SI0994863T1 (nl)
SK (2) SK283685B6 (nl)
TR (2) TR199801630T1 (nl)
TW (2) TW403740B (nl)
UY (1) UY25844A1 (nl)
WO (2) WO1998056773A1 (nl)
ZA (2) ZA984966B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
DE60319980T2 (de) * 2002-05-31 2009-04-16 Schering Corporation Xanthin-phosphodiesterase-v-hemmer polymorphe
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) * 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
WO2011028288A1 (en) * 2009-09-04 2011-03-10 Tactical Therapeutics, Inc Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
ES2498267T3 (es) 2010-04-30 2014-09-24 Laboratorios Lesvi, S.L. Procedimiento mejorado para la preparación de un intermedio de rufinamida
ITMI20110718A1 (it) * 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
EP0484437A4 (en) 1989-07-27 1994-06-01 Searle & Co Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
WO1992007847A1 (en) 1990-11-06 1992-05-14 Yamanouchi Pharmaceutical Co., Ltd. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
ATE194607T1 (de) 1995-02-22 2000-07-15 Hoechst Japan Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
EP0918758B1 (en) * 1996-07-11 2002-05-02 Novartis AG Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
HU225153B1 (en) 2006-07-28
PL192114B1 (pl) 2006-08-31
ID27660A (id) 2001-04-19
JP3672575B2 (ja) 2005-07-20
NO983666D0 (no) 1998-08-11
AU725517B2 (en) 2000-10-12
AR061004A2 (es) 2008-07-30
DE69813560T2 (de) 2004-02-05
SK283734B6 (sk) 2003-12-02
BR9804947A (pt) 1999-08-24
WO1998056772A1 (en) 1998-12-17
HUP0000798A2 (hu) 2000-10-30
HK1028242A1 (en) 2001-02-09
TW526195B (en) 2003-04-01
UY25844A1 (es) 2001-08-27
US20040167186A1 (en) 2004-08-26
CA2256013C (en) 2007-10-16
JP2000516258A (ja) 2000-12-05
CN1572789A (zh) 2005-02-02
HK1028241A1 (en) 2001-02-09
CZ253498A3 (cs) 1999-04-14
PE79799A1 (es) 1999-09-03
HU226107B1 (en) 2008-04-28
CN1132820C (zh) 2003-12-31
DE122007000051I2 (de) 2009-02-19
SK283685B6 (sk) 2003-12-02
SK109498A3 (en) 1998-12-02
AR061005A2 (es) 2008-07-30
DK0994864T3 (da) 2003-07-21
DK0994863T3 (da) 2003-05-26
US8076362B2 (en) 2011-12-13
IL125732A0 (en) 1999-04-11
DE122007000051I1 (de) 2007-11-08
FR07C0037I1 (nl) 2007-08-17
US6740669B1 (en) 2004-05-25
EP0994864B1 (en) 2003-04-16
HUP0000798A3 (en) 2000-10-30
IL125732A (en) 2002-12-01
CO4940448A1 (es) 2000-07-24
PT994864E (pt) 2003-07-31
CY2007014I1 (el) 2009-11-04
HUP0002113A2 (hu) 2001-02-28
DE69811500T2 (de) 2004-04-01
IL125733A (en) 2002-12-01
AU8437298A (en) 1998-12-30
AR012946A1 (es) 2000-11-22
NZ331371A (en) 2000-08-25
ATE232852T1 (de) 2003-03-15
AU8437198A (en) 1998-12-30
EP0994863A1 (en) 2000-04-26
AR012945A1 (es) 2000-11-22
CA2256015A1 (en) 1998-12-17
KR100425656B1 (ko) 2004-05-17
CA2614926C (en) 2010-02-09
ATE237599T1 (de) 2003-05-15
US6455556B2 (en) 2002-09-24
US20060116520A1 (en) 2006-06-01
ES2192779T3 (es) 2003-10-16
DE69813560D1 (de) 2003-05-22
CZ292260B6 (cs) 2003-08-13
ES2197485T3 (es) 2004-01-01
JP3672574B2 (ja) 2005-07-20
SK109398A3 (en) 1998-12-02
NO983667L (no) 1998-12-17
NZ331370A (en) 2000-08-25
ID21014A (id) 1999-04-08
CA2614926A1 (en) 1998-12-17
TW403740B (en) 2000-09-01
DE69811500D1 (de) 2003-03-27
PL330798A1 (en) 1999-06-07
KR19990087836A (ko) 1999-12-27
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
CN1217716A (zh) 1999-05-26
KR19990087835A (ko) 1999-12-27
US7750028B2 (en) 2010-07-06
RU2198167C2 (ru) 2003-02-10
PL330764A1 (en) 1999-05-24
US20100310655A1 (en) 2010-12-09
SI0994863T1 (en) 2003-08-31
EP0994864A1 (en) 2000-04-26
LU91345I9 (nl) 2018-12-31
BR9804946A (pt) 1999-08-24
RU2194041C2 (ru) 2002-12-10
CZ292481B6 (cs) 2003-09-17
CY2007014I2 (el) 2009-11-04
HK1028031A1 (en) 2001-02-02
JP2000516259A (ja) 2000-12-05
IL125733A0 (en) 1999-04-11
CZ253398A3 (cs) 1999-04-14
MY120156A (en) 2005-09-30
CA2256015C (en) 2008-06-03
EP0994863B1 (en) 2003-02-19
US20030125568A1 (en) 2003-07-03
US20010037029A1 (en) 2001-11-01
FR07C0037I2 (nl) 2008-05-16
ZA984966B (en) 1999-01-11
KR100409168B1 (ko) 2004-01-31
PE80999A1 (es) 1999-09-06
NO329314B1 (no) 2010-09-27
LU91345I2 (fr) 2007-09-04
SI0994864T1 (en) 2003-10-31
CN1298708C (zh) 2007-02-07
CN1159300C (zh) 2004-07-28
PL191943B1 (pl) 2006-07-31
TR199801630T1 (xx) 1999-06-21
MY125854A (en) 2006-08-30
HUP0002113A3 (en) 2002-09-30
NO983666L (no) 1998-12-17
CN1259127A (zh) 2000-07-05
CO4940452A1 (es) 2000-07-24
CA2256013A1 (en) 1998-12-17
TR199801631T1 (xx) 1999-06-21
WO1998056773A1 (en) 1998-12-17
AU725528B2 (en) 2000-10-12
NO329315B1 (no) 2010-09-27
ZA984967B (en) 1999-01-11

Similar Documents

Publication Publication Date Title
NL300284I2 (nl) Kristalmodificatie van
NO331016B1 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat
ID25660A (id) Teripatide kristal
DE69829356D1 (de) Anzeige
EP0932137A4 (en) INDICATOR
DE69805692D1 (de) Uhrenarmband
NO20003081D0 (no) Glykagonlignende peptid-1-krystaller
DE69822774D1 (de) Armbanduhr
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
ID24458A (id) Modifikasi rheologi in-sito poliolefin
DE69826349D1 (de) Flüssigkristallanzeige
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
PT779859E (pt) Conjuntos de cristais orientados
ID24270A (id) Penghilang sumbatan keratotik
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
DE69823908D1 (de) Einkristallziehvorrichtung
NO970910D0 (no) Spirostanylglykosidal-krystaller
DE59811318D1 (de) Anzeigeeinrichtung
DE69508469D1 (de) Oxyde-Granat-Einkristall
DE69920662D1 (de) Sibe-kristall
ZA9810718B (en) Novel crystal modification of thiazine-indigo
KR980004887U (ko) 표지판
KR970002716U (ko) 액정표시소자
KR970020858U (ko) 휠체어 탑승형 장애인 운송용 승합차량
KR960015044A (ko) 액정표시소자